Federal Register of Legislation - Australian Government

Primary content

PB 9 of 2011 Determinations/Health as made
This Determination amends the National Health (Listed drugs on F1 or F2) Determination 2010 (No. PB 93 of 2010) to provide for allocation of drugs to the F1 and F2 formularies for the Pharmaceutical Benefits Scheme.
Administered by: Health
Registered 31 Jan 2011
Tabling HistoryDate
Tabled HR08-Feb-2011
Tabled Senate09-Feb-2011
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

National Health (Listed drugs on F1 or F2) Amendment Determination 2011

Instrument number PB 9 of 2011

National Health Act 1953

I, FELICITY MCNEILL, Acting First Assistant Secretary, Department of Health and Ageing, delegate of the Minister of Health and Ageing, make this Determination under subsection 85AB(1) of the National Health Act 1953.

Dated            27  January  2011

 

FELICITY MCNEILL

 

Acting First Assistant Secretary

Department of Health and Ageing

1              Name of Determination

         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2010.

         (2)   This Determination may also be cited as PB 9 of 2011.

2              Commencement

                This Determination commences on 1 February 2011.

3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination  2010 (PB 93 of 2010).


Schedule 1             Amendments

 

(Section 3)

 

[1]     Schedule 1, after item dealing with Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids

                  

Insert

 

          Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides

 

[2]     Schedule 1, after item dealing with Aurothiomalate

                  

Insert

 

                     Azacitidine

 

[3]     Schedule 1, after item dealing with Duloxetine

                  

Insert

 

          Dutasteride

 

[4]     Schedule 1, after item dealing with Ustekinumab

                  

Omit

 

          Valaciclovir

 

[5]     Schedule 2, after item dealing with Calcitriol

                  

Omit

 

          Clarithromycin

 

[6]     Schedule 2, after item dealing with Clarithromycin

                  

Insert

 

          Clindamycin

 

[7]     Schedule 2, after item dealing with Perindopril

                  

Insert

 

          Perindopril with amlodipine

 

 

 

[8]     Schedule 2, after item dealing with Trimethoprim with sulfamethoxazole

                  

Insert

 

          Valaciclovir         

 

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.